Citi lowered the firm’s price target on Eastman Chemical to $85 from $86 and keeps a Buy rating on the shares post the Q3 report. The firm sees further challenges in 2023 for the company buy a compelling setup in 2024. Eastman’s volume/mix declines continue to be the biggest driver of earnings declines, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EMN: